Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim

Last Updated: March 24, 2023

Details for Patent: 6,142,145

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

Summary for Patent: 6,142,145
Title: Inhalation device
Abstract:An inhaler for administering powder by inhalation, including an inhaler body having two ends and a peripheral wall therebetween; an inhalation unit disposed in the inhaler body, the inhalation unit comprising an inhalation channel, the inhalation channel having an air inlet and an outlet; a dosing unit disposed in the inhaler body for providing a dose of powder to the inhalation channel such that a stream of air containing powder may be drawn from the outlet of the inhalation channel on inhalation by a user; a divider having a first surface bounded by a periphery and which substantially closes one end of the inhaler body; a mouthpiece attached to the periphery of the divider, the mouthpiece having a substantially radially directed flange which provides a second surface and which, together with the first surface, defines an air chamber; a first inlet for the air chamber provided in the first surface within the periphery of the divider and in fluid communication with the outlet of the inhalation channel; a second inlet for the air chamber disposed in the first surface within the periphery of the divider and adjacent the first inlet, a stream of supplementary air in use being drawn through the second inlet on inhalation by the user; and a discrete opening in peripheral wall of the inhaler body which is in fluid communication with the second inlet of the air chamber.
Inventor(s): Dagsland; Allan (Karlshamn, SE), Malmqvist-Granlund; Karin (Kavlinge, SE), Virtanen; Risto (Nurmijarvi, FI)
Assignee: Astra Aktiebolag (Sodertalje, SE)
Application Number:09/068,379
Patent Claim Types:
see list of patent claims

Drugs Protected by US Patent 6,142,145

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 6,142,145

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Sweden9700940Mar 14, 1997
PCT Information
PCT FiledMarch 13, 1998PCT Application Number:PCT/SE98/00460
PCT Publication Date:September 24, 1998PCT Publication Number: WO98/41259

International Family Members for US Patent 6,142,145

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 6430698 See Plans and Pricing
European Patent Office 0975382 See Plans and Pricing
Sweden 9700940 See Plans and Pricing
World Intellectual Property Organization (WIPO) 9841259 See Plans and Pricing
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.